Triple Therapy-Based on Tegoprazan, a New Potassium-Competitive Acid Blocker, for First-Line Treatment of <i>Helicobacter pylori</i> Infection: A Randomized, Double-Blind, Phase III, Clinical Trial

Yoon Jin Choi, Jae Young Jang, Jung Mogg Kim et al.|Gut and Liver|2022

Cited by 86